ReviewPharmacology & therapeutics2009

Novel therapeutics for type 2 diabetes: incretin hormone mimetics (glucagon-like peptide-1 receptor agonists) and dipeptidyl peptidase-4 inhibitors.

E J VerspohlPubMed ↗Publisher ↗

No numbers read from the abstract.